|
CN111978377A
|
|
COVID-19 antigen, preparation method and application
|
|
CN111004324A
|
|
Calprotectin monoclonal antibody and application thereof
|
|
CN111269314A
|
|
anti-CK 18 monoclonal antibody and application thereof
|
|
CN111063440A
|
|
Early non-alcoholic fatty liver disease evaluation model, construction method and application thereof
|
|
CN109879941A
|
|
Flagellum L polypeptide, antibody capture device and kit
|
|
CN109884309A
|
|
Enterobacteriaceae polypeptide, antibody capture device and kit
|
|
CN109884310A
|
|
Enterobacteriaceae ospa polypeptide, antibody capture device and kit
|
|
CN109884291A
|
|
Campylobacter spp polypeptide, antibody capture device and kit
|
|
CN109879948A
|
|
Flagellum polypeptide, antibody capture device and kit
|
|
CN109884295A
|
|
Pseudomonad polypeptide, antibody capture device and kit
|
|
CN109884311A
|
|
Enterobacteria polypeptide, antibody capture device and kit
|
|
CN109879940A
|
|
Flagellum G polypeptide, antibody capture device and kit
|
|
CN109879967A
|
|
A kind of preparation method and application of acetylglucosamine conjugate
|
|
CN109884308A
|
|
Mannocarolose haptens, conjugate and application
|
|
CN108535490A
|
|
Biological agent blood concentration detection method and reagent
|
|
CN108265034A
|
|
Hybridoma cell strain and its anti-CK18-M30 monoclonal antibodies of generation and application
|
|
CN108267586A
|
|
A kind of people CK18 protein assay reagents and preparation method thereof
|
|
CN108265031A
|
|
Anti- CBirl hybridoma cell strains and its monoclonal antibody of generation
|
|
CN108265032A
|
|
Anti- OmpC hybridoma cell strains and its monoclonal antibody of generation
|
|
CN108265033A
|
|
Anti- I2 hybridoma cell strains and its monoclonal antibody of generation
|
